Publications by authors named "Andrew Winokur"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

837

Total Likes

184

Extended Reach

950,419

Social Features

96
E
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Ella J Daly, Madhukar H Trivedi, Adam Janik, Honglan Li, Yun Zhang, Xiang Li, Rosanne Lane, Pilar Lim, Anna R Duca, David Hough

JAMA Psychiatry· September 2019

Videos about Article: user user

2 3 94 4 47 2

View All Article and Social Media Activity
L
Longitudinal Course of Adverse Events With Esketamine Nasal Spray: A Post Hoc Analysis of Pooled Data From Phase 3 Trials in Patients With Treatment-Resistant Depression.
David J Williamson, Jagadish P Gogate, Jennifer K Kern Sliwa, Lewis S Manera, Sheldon H Preskorn, Andrew Winokur

J Clin Psychiatry· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subanalysis of the CYP-GUIDES Trial: CYP2D6 Functional Stratification and Operational Timeline Selection.
Gualberto Ruaño, Joseph Tortora, Saskia Robinson, Seth Baker, Theodore Holford, Andrew Winokur

Psychiatry Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep Patterns and Neuropsychiatric Symptoms in Hospitalized Patients With Dementia.
Kaloyan S Tanev, Andrew Winokur, Roger K Pitman

J Neuropsychiatry Clin Neurosci· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial.
Ella J Daly, Jaskaran B Singh, Maggie Fedgchin, Kimberly Cooper, Pilar Lim, Andrew Winokur

JAMA Psychiatry· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.
Jaskaran B Singh, Maggie Fedgchin, Ella J Daly, Peter De Boer, Kimberly Cooper, Andrew Winokur

Am J Psychiatry· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Relationship Between Sleep Disturbances and Psychiatric Disorders: Introduction and Overview.
Andrew Winokur

Psychiatr Clin North Am· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep Disturbances in Schizophrenia.
Jayesh Kamath, Sundeep Virdi, Andrew Winokur

Psychiatr Clin North Am· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep Disorders and Mental Health.
Andrew Winokur, Jayesh Kamath

Psychiatr Clin North Am· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.
George I Papakostas, Ottavio V Vitolo, Waguih W Ishak, Mark H Rapaport, John M Zajecka, Andrew Winokur

J Clin Psychiatry· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyrotropin-releasing hormone as a treatment for cancer-related fatigue: a randomized controlled study.
Jayesh Kamath, Richard Feinn, Andrew Winokur

Support Care Cancer· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New approaches for the treatment of sleep disorders.
Nicholas A DeMartinis, Jayesh Kamath, Andrew Winokur

Adv Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of psychiatric medications on sleep and sleep disorders.
Nicholas A DeMartinis, Andrew Winokur

CNS Neurol Disord Drug Targets· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression.
Martin P Szuba, Jay D Amsterdam, Antonio T Fernando, Keith A Gary, Peter C Whybrow, Andrew Winokur

J Clin Psychopharmacol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amantadine for weight gain associated with olanzapine treatment.
Walter Deberdt, Andrew Winokur, Patrizia A Cavazzoni, Quynh N Trzaskoma, Christopher D Carlson

Eur Neuropsychopharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression.
Mark S Kramer, Andrew Winokur, Jeffrey Kelsey, Sheldon H Preskorn, Anthony J Rothschild

Neuropsychopharmacology· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Andrew Winokur, Nicholas A DeMartinis, Daniel P McNally, Ellen M Gary, Jennifer L Cormier

J Clin Psychiatry· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics.
Keith A Gary, Kevin A Sevarino, George G Yarbrough, Arthur J Prange, Andrew Winokur

J Pharmacol Exp Ther· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis